Clinical and Experimental Pediatrics

대한소아청소년과학회 (The Korean Pediatric Society)
권호 표지
DOI QR코드

DOI QR Code

사람의 동종 조혈모세포이식에서 CD4+CD25+ T세포의 분포와 이식편대숙주병

Distribution of CD4+CD25+ T cells and graft-versus-host disease in human hematopoietic stem cell transplantation

  • 이대형 (한림대학교 의과대학 소아과학교실) ;
  • 정낙균 (가톨릭대학교 의과대학 소아과학교실) ;
  • 정대철 (가톨릭대학교 의과대학 소아과학교실) ;
  • 조빈 (가톨릭대학교 의과대학 소아과학교실) ;
  • 김학기 (가톨릭대학교 의과대학 소아과학교실)
  • Lee, Dae Hyoung (Department of Pediatrics, College of Medicine, Hallym University) ;
  • Chung, Nak Gyun (Department of Pediatrics, College of Medicine, The Catholic University of Korea) ;
  • Jeong, Dae Chul (Department of Pediatrics, College of Medicine, The Catholic University of Korea) ;
  • Cho, Bin (Department of Pediatrics, College of Medicine, The Catholic University of Korea) ;
  • Kim, Hack Ki (Department of Pediatrics, College of Medicine, The Catholic University of Korea)
  • 투고 : 2008.07.29
  • 심사 : 2008.11.03
  • 발행 : 2008.12.15
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

목 적: 본 연구의 목적은 사람의 동종 조혈모세포이식에서 공여자의 이식편과 환자의 이식 후 말초혈액에서 $CD4^+CD25^+$ T 세포 분획의 분포를 알아보고 급성 이식편대숙주병(GVHD)과 연관성을 알아보고자 하였다. 방 법: 동종 조혈모세포이식을 시행 받은 17명의 소아를 대상으로 하였다. 공여자의 이식편과 이식 받은 환자의 이식 후 말초혈액으로부터 얻은 검체를 유세포 분석(flow cytometry)하였다. 공여자의 이식편과 이식 후 1개월과 3개월에 환자의 말초혈액 내 $CD4^+CD25^+$ T 세포의 분획과 절대 세포수를 알아보았다. 결 과: 공여자의 이식편 내 $CD4^+CD25^+$ T 세포의 분획은 급성 GVHD 발생군과 비발생군에서 각각 0.90%, 1.06%이었으며 차이가 없었다(P=0.62). 이식편 내 $CD4^+CD25^+$ T세포의 절대수는 급성 GVHD 발생군과 비발생군이 각각 $6.18{\times}10^5/kg$와 $25.85{\times}10^5/kg$으로 급성 GVHD 비발생군이 발생군보다 많은 경향을 보였으나 유의성은 없었다(P=0.09). 급성 GVHD 비발생군의 말초혈액 $CD4^+CD25^+$ T 세포는 이식 후 1개월에 2.11%, 3개월에 1.43%로 유의하게 감소하였으나(P=0.028), 급성 GVHD 발생군의 말초혈액 내 $CD4^+CD25^+$ T 세포는 이식 후 1개월과 3개월에 각각 2.47%와 2.30%로 유의한 차이가 없었다(P=0.50). 결 론: 본 실험을 통하여 저자들은 공여자의 이식편 내 $CD4^+CD25^+$ T세포의 분포와 이식 후 환자의 급성 GVHD의 관계에 대한 유의성은 검증할 수 없었으며 이식 후 환자의 말초혈액 내 $CD4^+CD25^+$ T 세포에는 조절 T세포보다 GVHD와 연관된 활성화된 T세포의 분획이 더 클 것으로 사료되나 추가적인 조절 T세포의 표지자를 이용한 검증이 필요할 것으로 사료된다.

Purpose : This study aimed to determine the frequencies of $CD4^+CD25^+$ T cells in donor graft and peripheral blood $CD4^+CD25^+$ T cells in recipients after hematopoietic stem cell transplantation (HSCT) and their association with graft-versus-host disease (GVHD). Methods : Seventeen children who underwent HSCT were investigated. $CD4^+CD25^+$ T cells in samples from donor grafts and recipient peripheral blood were assessed by flow cytometry at 1 and 3 months after transplantation. Results : $CD4^+CD25^+$ T cell frequencies in the grafts showed no significant difference between patients with and without acute GVHD (0.90% vs. 1.06%, P=0.62). Absolute $CD4^+CD25^+$ T cell number in grafts were lower in patients with acute GVHD than in those without acute GVHD ($6.18{\times}10^5/kg$ vs. $25.85{\times}10^5/kg$, P=0.09). Patients without acute GVHD showed a significant decrease in peripheral blood $CD4^+CD25^+$ T cell percentage at 3 months compared to those at 1 month after HSCT (2.11% vs. 1.43%, P=0.028). However, in patients with acute GVHD, $CD4^+CD25^+$ T cell percentage at 3 months was not different from the corresponding percentage at 1 month after HSCT (2.47% vs. 2.30%, P=0.5). Conclusion : The effect of frequencies of $CD4^+CD25^+$ T cells in donor grafts on acute GVHD after HSCT could not be identified, and the majority of peripheral blood $CD4^+CD25^+$ T cells in patients who underwent HSCT may be activated T cells related to acute GVHD rather than regulatory T cells. Further studies with additional markers for regulatory T cells are needed to validate our results.

키워드

참고문헌

  1. Ferrara JL, Reddy P. Pathophysiology of graft-versus-host disease. Semin Hematol 2006;43:3-10 https://doi.org/10.1053/j.seminhematol.2005.09.001
  2. Teshima T, Ferrara JL. Pathogenesis and prevention of graft-versus-host disease. Curr Opin Organ Transplant 2001; 6:265-71 https://doi.org/10.1097/00075200-200109000-00012
  3. Martin PJ, Hansen JA, Buckner CD, Sanders JE, Deeg HJ, Stewart P, et al. Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts. Blood 1985;66:664-72
  4. Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey J, Kolb HJ, et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 1990;75:555-62
  5. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995;155:1151-64
  6. Wood KJ, Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immuno. 2003;3:199-210 https://doi.org/10.1038/nri1027
  7. Trenado A, Charlotte F, Fisson S, Yagello M, Klatzmann D, Salomon BL, et al. Recipient-type specific $CD4^＋CD25^＋$ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versusleukemia. J Clin Invest 2003;112:1688-96 https://doi.org/10.1172/JCI17702
  8. Jones SC, Murphy GF, Korngold R. Post-hematopoietic cell transplantation control of graft-versus-host disease by donor $CD4^＋CD25^＋$ T cells to allow an effective graft-versusleukemia response. Biol Blood Marrow Transplant 2003;9: 243-56 https://doi.org/10.1053/bbmt.2003.50027
  9. Sakaguchi S, Sakaguchi N, Shimizu J, Yamazaki S, Sakihama T, Itoh M, et al. Immunologic tolerance maintained by $CD4^＋CD25^＋$ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev 2001;182:18-32 https://doi.org/10.1034/j.1600-065X.2001.1820102.x
  10. Hoffmann P, Ermann J, Edinger M, Fathman CG, Strober S. Donor-type $CD4^＋CD25^＋$ regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation J Exp Med 2002;196:389-99 https://doi.org/10.1084/jem.20020399
  11. Cohen JL, Trenado A, Vasey D, Klatzmann D, Salomon BL. $CD4^＋CD25^＋$ immunoregulatory T cells: new therapeutics for graft-versus-host disease. J Exp Med 2002;196:401-6 https://doi.org/10.1084/jem.20020090
  12. Taylor PA, Lees CJ, Blazar BR. The infusion of ex vivo activated and expanded $CD4^＋CD25^＋$ immune regulatory cells inhibits graft-versus-host disease lethality. Blood 2002;99: 3493-9 https://doi.org/10.1182/blood.V99.10.3493
  13. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974;18:295-304 https://doi.org/10.1097/00007890-197410000-00001
  14. Hanash AM, Levy RB. Donor $CD4^＋CD25^＋$ T cells promote engraftment and tolerance following MHC-mismatched hematopoietic cell transplantation. Blood 2005;105:1828-36 https://doi.org/10.1182/blood-2004-08-3213
  15. Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA. $CD4^＋$ CD25high Regulatory cells in human peripheral blood. J Immunol 2001;167:1245-53 https://doi.org/10.4049/jimmunol.167.3.1245
  16. Stanzani M, Martins SL, Saliba RM, St John LS, Bryan S, Couriel D, et al. CD25 expression on donor CD4 or CD8 T cells is associated with an increased risk for graft-versushost disease after HLA-identical stem cell transplantation in humans. Blood 2004;103:1140-6 https://doi.org/10.1182/blood-2003-06-2085
  17. Clark FJ, Gregg R, Piper K, Dunnion D, Freeman L, Griffiths M, et al. Chronic graft-versus-host disease is associated with increased numbers of peripheral blood $CD4^＋$ CD25 high regulatory T cells. Blood 2004;103:2410-6 https://doi.org/10.1182/blood-2003-06-2073
  18. Sanchez J, Casano J, Alvarez MA, Roman-Gomez J, Martin C, Martinez F, Gomez P, et al. Kinetic of regulatory CD25high and activated $CD134^＋$(OX40) T lymphocytes during acute and chronic graft-versus-host disease after allogeneic bone marrow transplantation. Br J Haematol 2004;126:697-703 https://doi.org/10.1111/j.1365-2141.2004.05108.x
  19. Miura Y, Thoburn CJ, Bright EC, Phelps ML, Shin T, Matsui WH, et al. Association of Foxp3 regulatory gene expression with graft-versus-host disease. Blood 2004;104: 2187-93 https://doi.org/10.1182/blood-2004-03-1040
  20. Zorn E, Kim HT, Lee SJ, Floyd BH, Lista D, Arumugarajah S, et al. Reduced frequency of FOXP3＋ $CD4^＋CD25^＋$ regulatory T cells in patients with chronic graft-versus-host disease. Blood 2005;106:2903-11 https://doi.org/10.1182/blood-2005-03-1257
  21. Auletta JJ, Lazarus HM. Immune restoration following hematopoietic stem cell transplantation: an evolving target. Bone Marrow Transplant 2005;35:835-57 https://doi.org/10.1038/sj.bmt.1704966
  22. Storek J, Witherspoon RP. Immunological reconstitution after hematopoietic stem cell transplantation. In: Atkinson K, Champlin R, Ritz J, Fibbe WE, Ljungman P, Brenner MK. Clinical bone marrow and blood stem cell transplantation, 3rd ed. Cambridge: Cambridge University Press, 2004:194-226